Log in
Forgot password


Longevity & the Future of Health — With Holiday Dinner to Follow

  • 2025-12-01
  • 6:30 PM - 9:00 PM
  • Donato Enoteca, 1041 Middlefield Rd., Redwood City, CA

Registration

  • Admission ticket in-person at venue, including food and beverage. Special price for members. See the Membership page for details.
  • Regular (Non-Member) price. Includes food and beverage.
Registration is closed


LONGEVITY & THE FUTURE OF HEALTH

With Holiday Dinner to Follow

We invite you to join iTAL on December 1st for an evening dedicated to longevity, health, and the breakthroughs shaping the future of medicine. 

Special panel with Prof. Ronjon Nag, Dr. Benedetta di Robilant, and

Dr. Marco Quarta


Enjoy an evening of longevity insights paired with seasonal, Italian dishes from Donato Enoteca, crafted with the fresh, simple ingredients that define authentic Italian cuisine


*** ABOUT OUR SPECIAL GUESTS ***

PROF. RONJON NAG

Stanford professor of Medicine and Silicon Valley hall of Fame 2023  whose work has shaped the evolution of AI and advanced technologies for human health. He now leads R42 Group, investing in breakthroughs that accelerate longevity and the future of medicine.

DR. BENEDETTA DI ROBILANT

Founder of Dorian Therapeutics, acquired by Altos Lab in 2025 Leader in biotechnology and precision health, with a career spanning scientific innovation, venture development, and global health strategy.  

DR. MARCO QUARTA

Scientist and entrepreneur known for his pioneering work in aging biology, stem cells, and regenerative medicine. As co-founder of Rubedo Life Sciences, he focuses on developing therapies that target the root causes of aging to extend human health-span.


SPONSORS & DONORS

Sponsors & Donors help fund our Programs, so we are deeply thankful to them.

iTAL Foundation is a 501(c)(3) Nonprofit Organization. Tax ID: 24-1468921. Donations are tax-deductible. 
iTAL™ is a trademark of iTAL Foundation

Engage with iTAL: come to an event or visit the contact page to sign up for our newsletter or reach out to us.